USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
EFFIGENE PHARMACEUTICALS, INC.
Address:
EFFIGENE PHARMACEUTICALS, INC.
c/o Emtech Bio
ATLANTA, GA 30306
Phone:
N/A
URL:
N/A
EIN:
126083117
DUNS:
808050327
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $215,382.00 2

Award List:

Developing Adjuvant SiRNA Therapy for Huntington's Disease

Award Year / Program / Phase:
2008 / STTR / Phase I
Award Amount:
$99,960.00
Agency:
HHS
Principal Investigator:
Research Institution:
N/A
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): SiRNAs are synthetic double-stranded oligonucleotides of ~21 base pairs. When applied to cells, siRNAs can effectively and specifically silence their target genes, called RNA interference (RNAi). RNAi has become attract ive tool for functional genomics and a… More

Developing Small Molecules to Potentiate RNA Interference

Award Year / Program / Phase:
2009 / STTR / Phase I
Award Amount:
$115,422.00
Agency:
HHS
Principal Investigator:
Peng Jin
Research Institution:
EMORY UNIVERSITY
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): SiRNAs are synthetic double-stranded oligonucleotides of ~21 base pairs. When applied to cells, siRNAs can effectively and specifically silence their target genes, called RNA interference (RNAi). RNAi has become attract ive tool for functional genomics and a… More